| тип : |
Лаборатория |
|
| Исследовательские группы : |
|
| Авторы : |
|
| Заголовок : |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021 |
| Номер : |
Sanofi Genzyme 2021 |
|
| Уровень доказательности : |
|
| Физическая стабильность : |
|
| Химическая стабильность : |
|
| Другие методы : |
|
| Комментарии : |
|
Списки
 Isatuximab
|
 |
 |
 |
 |
? mg/ml |
15-25°C |
 |
| 8 |
 |
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
 |
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
| |
+
|
|
|
|
|
| |
+
|
|
|
|
